FDA may revoke Pfizer’s Covid vaccine for children under 5, Bloomberg reports

The FDA is considering pulling Pfizer’s (PFE) authorization to sell its Covid vaccine for children under the age of 5, Bloomberg’s Damian Garde reports. Pfizer has requested the authorization remain as it is through the coming fall season and is “currently in discussions with the agency on potential paths forward,” the company said. Pfizer’s vaccine remains approved for children over 5, and the company expects it to win full approval in that age group before Covid season hits in the fall, according to a person familiar with the matter. Moderna’s (MRNA) competing vaccine is approved for children under 12 who are at increased risk of the disease due to one or more underlying conditions, the report notes.